ISSN: 2545-2533     choose language:  

2024; 7(3): 25-34

DOI: 10.32114/CCI.2024.7.3.25.34
Published online: 2024-09-30 (first online 2024-05-08)

Association of serum albumin and serum high-sensitivity C-reactive protein levels with acute ischemic stroke severity.


Mohit Choudhary [1] , Shailesh Kumar [1] , Rupesh Yadav [2] .

[1] Department of Medicine, Atal Bihari Vajpayee Institute of Medical Sciences and Dr RML Hospital, New Delhi, India
[2] Department of Anesthesiology, Atal Bihari Vajpayee Institute of Medical Sciences and Dr RML Hospital, New Delhi, India



    Abstract:


Abstract [EN]   - INTRODUCTION: Acute ischemic stroke, a type of cerebrovascular disease, is one of the most common causes of mortality and morbidity around the world. Albumin-induced neuroprotection can be attributed to properties such as reversal of thrombosis, improvement in microvascular blood perfusion, reduction in brain swelling. The increase in high-sensitivity C-reactive protein levels (hs-CRP) after an ischemic stroke suggests a systemic inflammatory response and reveals the degree of brain damage. The purpose of the study was to assess the association of serum albumin and serum high-sensitivity C-reactive protein levels with acute ischemic stroke severity. MATERIALS AND METHODS: Prospective cross-sectional observational study involving 90 patients admitted to the emergency department that met the inclusion and exclusion criteria. At the time of admission blood samples were taken for measurement of serum albumin level (normal albumin level ≥3.5 g/dl and hypoalbuminemia <3.5 g/dl), hs-CRP (low risk <1.0 mg/L; average risk 1.0-3.0 mg/L; high risk >3.0 mg/L). The severity of stroke was assessed using the National Institutes of health stroke scale (NIHSS) score. RESULTS: 60% of the cases had a normal albumin level, while 40% of the cases had hypoalbuminemia. 82.22% of the cases had a high risk level of hs-CRP, while only 1.11% of the cases had a low risk level of hs-CRP. The association of hypoalbuminemia and hs-CRP with stroke severity on the NIHSS score measured at the time of admission. It was observed that there was a statistically significant correlation between hypoalbuminemia with stroke severity (p-value <0.002) and between hs-CRP levels with stroke severity (p-value <0.013). CONCLUSIONS: The study concluded that the association between low serum albumin level and elevated hs-CRP levels with the severity of acute ischemic stroke was statistically significant.

Streszczenie [PL]   - WSTĘP: Ostry udar niedokrwienny, rodzaj choroby naczyń mózgowych, jest jedną z najczęstszych przyczyn śmiertelności i zachorowalności na całym świecie. Neuroprotekcję wywołaną przez albuminę można przypisać takim właściwościom, jak odwrócenie zakrzepicy, poprawa mikronaczyniowego przepływu krwi, zmniejszenie obrzęku mózgu. Wzrost poziomów białka C-reaktywnego o wysokiej czułości (hs-CRP) po udarze niedokrwiennym sugeruje ogólnoustrojową odpowiedź zapalną i ujawnia stopień uszkodzenia mózgu. Celem badania była ocena związku stężenia albuminy w surowicy i stężenia białka C-reaktywnego o wysokiej czułości w surowicy z ciężkością ostrego udaru niedokrwiennego. MATERIAŁY I METODY: Prospektywne badanie obserwacyjne przekrojowe z udziałem 90 pacjentów przyjętych na oddział ratunkowy, którzy spełnili kryteria włączenia i wyłączenia. W momencie przyjęcia pobrano próbki krwi w celu zmierzenia poziomu albumin w surowicy (normalny poziom albumin ≥3,5 g/dl i hipoalbuminemia <3,5 g/dl), hs-CRP (niskie ryzyko <1,0 mg/l; średnie ryzyko 1,0-3,0 mg/l; wysokie ryzyko >3,0 mg/l). Ciężkość udaru oceniano za pomocą skali udaru National Institutes of Health (NIHSS). WYNIKI: 60% przypadków miało prawidłowy poziom albumin, podczas gdy 40% przypadków miało hipoalbuminemię. 82,22% przypadków miało wysoki poziom ryzyka hs-CRP, podczas gdy tylko 1,11% przypadków miało niski poziom ryzyka hs-CRP. Związek hipoalbuminemii i hs-CRP z ciężkością udaru w punktacji NIHSS mierzonej w momencie przyjęcia. Zaobserwowano, że istniała statystycznie istotna korelacja między hipoalbuminemią a ciężkością udaru (wartość p <0,002) i między poziomami hs-CRP a ciężkością udaru (wartość p <0,013). WNIOSKI: Badanie wykazało, że związek między niskim poziomem albuminy w surowicy i podwyższonym poziomem hs-CRP a ciężkością ostrego udaru niedokrwiennego był statystycznie istotny.

    Citation:


VANCOUVER FORMAT

Choudhary M, Kumar S, Yadav R. Association of serum albumin and serum high-sensitivity C-reactive protein levels with acute ischemic stroke severity. Crit. Care Innov. 2024; 7(3): 25-34.
DOI: 10.32114/CCI.2024.7.3.25.34


    Download article (PDF file): click here



    Read article:





    Additional materials:


No files


    References:


[1] Jones SP, Baqai K, Clegg A, Georgiou R, Harris C, Holland EJ, et al.. Stroke in India: A systematic review of the incidence, prevalence, and case fatality. Int J Stroke. 2022; 17(2): 132-140.
| Digital Object Identifier (DOI) | PubMed (NCBI) | Scholar Google |

[2] Che R, Huang X, Zhao W, Jiang F, Wu L, Zhang Z, et al.. Low Serum Albumin level as a Predictor of Hemorrhage Transformation after Intravenous Thrombolysis in Ischemic Stroke Patients. Sci Rep. 2017; 7(1): 7776.
| Digital Object Identifier (DOI) | PubMed (NCBI) | Scholar Google |

[3] Zhang Q, Lei YX, Wang Q, Jin YP, Fu RL, Geng HH, et al.. Serum albumin level is associated with the recurrence of acute ischemic stroke. Am J Emerg Med. 2016; 34(9): 1812-1816.
| Digital Object Identifier (DOI) | PubMed (NCBI) | Scholar Google |

[4] Shaikh F, Shaikh FH, Chandio SA. Frequency of Hypoalbuminemia and In-Hospital Mortality in Acute Ischemic Stroke Patients Presenting at a Tertiary Care Hospital, Hyderabad. Cureus 2021; 13(4): e14256.
| Digital Object Identifier (DOI) | PubMed (NCBI) | Scholar Google |

[5] Gao J, Zhao Y, Du M, Guo H, Wan T, Wu M, et al.. Serum Albumin Levels and Clinical Outcomes Among Ischemic Stroke Patients Treated with Endovascular Thrombectomy. Neuropsychiatr Dis Treat. 2021; 17: 401-411.
| Digital Object Identifier (DOI) | PubMed (NCBI) | Scholar Google |

[6] Roushdy T, Abdel Nasser A, Nasef A, Elbassiouny A, George J, Aref H. A clinical comparative analysis between expanded NIHSS and original NIHSS in posterior circulation ischemic stroke. J Clin Neurosci. 2023; 114: 77-80.
| Digital Object Identifier (DOI) | PubMed (NCBI) | Scholar Google |

[7] Khan MSA, Ahmad S, Ghafoor B, Shah MH, Mumtaz H, Ahmad W, et al.. Inpatient assessment of the neurological outcome of acute stroke patients based on the National Institute of Health Stroke Scale (NIHSS). Ann Med Surg (Lond). 2022 Oct; 82: 104770.
| Digital Object Identifier (DOI) | PubMed (NCBI) | Scholar Google |

[8] Liu Y, Wang J, Zhang L, Wang C, Wu J, Zhou Y, et al.. Relationship between C-reactive protein and stroke: a large prospective community based study. PLoS One. 2014; 9(9): e107017.
| Digital Object Identifier (DOI) | PubMed (NCBI) | Scholar Google |

[9] Jia M, Shi Y, Wang Y, Wang M, Zhang L, He Q, et al.. High-Sensitivity C-Reactive Protein and Ischemic Stroke in Patients with Nonalcoholic Fatty Liver Disease: A Prospective Study. J Healthc Eng. 2022; 2022: 9711712.
| Digital Object Identifier (DOI) | PubMed (NCBI) | Scholar Google |

[10] Zhang XL, Dong YT, Liu Y, Zhang Y, Li TT, Hu FY. Effects of dl-3-n-butylphthalide on serum lipoprotein-associated phospholipase A2 and hypersensitive C-reactive protein levels in acute cerebral infarction. Brain Behav. 2019; 9(12): e01469.
| Digital Object Identifier (DOI) | PubMed (NCBI) | Scholar Google |

[11] Haq EU, Qayyum A, Qayyum HA, Anam M, Khan AR, Ahmed K, et al.. Frequency of Hypoalbuminemia in Acute Ischemic Stroke patients Based on Stroke Severity. Pak J Med Health Sci. 2021; 15(6): 1335–1339.
| Digital Object Identifier (DOI) | Scholar Google |

[12] Alam MN, Rahman M, Showkat T, Halder PC, Das BK, Halder KC, et al.. Association of Serum C- Reactive Protein with Severity of Acute Ischemic Stroke Patients. Sch J Appl Med Sci. 2021; 9(12): 1867–1872.
| Digital Object Identifier (DOI) | Scholar Google |

[13] Elbaih AH, Elshaboury I, Ahmed R, Allah M. Validity and prognostic value of serum albumin level in emergency acute ischemic stroke egyptian patients. Med Sci Int Med J. 2018; 7(4): 736–744.
| Digital Object Identifier (DOI) | Scholar Google |

[14] Dziedzic T, Pera J, Slowik A, Gryz-Kurek EA, Szczudlik A. Hypoalbuminemia in acute ischemic stroke patients: frequency and correlates. Eur J Clin Nutr. 2007; 61(11): 1318-1322.
| Digital Object Identifier (DOI) | PubMed (NCBI) | Scholar Google |

[15] Chakraborty B, Vishnoi G, Goswami B, Gowda SH, Chowdhury D, Agarwal S. Lipoprotein(a), ferritin, and albumin in acute phase reaction predicts severity and mortality of acute ischemic stroke in North Indian Patients. J Stroke Cerebrovasc Dis. 2013; 22(7): e159-167.
| Digital Object Identifier (DOI) | PubMed (NCBI) | Scholar Google |

[16] Kasundra G, Sood I. Prognostic Significance Of Serum Albumin Levels In Acute Ischemic Stroke. Natl J Integr Res Med. 2014; 5(2): 1–4.
| Scholar Google |

[17] Ginsberg MD, Palesch YY, Hill MD, Martin RH, Moy CS, Barsan WG, et al.. High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. Lancet Neurol. 2013; 12(11): 1049-1058.
| Digital Object Identifier (DOI) | PubMed (NCBI) | Scholar Google |

[18] Mohan G, Kaur H, Narang N. A cross‑sectional study to correlate the levels of high sensitivity C‑reactive protein and size of infarct in ischemic stroke. APIK J Int Med. 2023.
| Digital Object Identifier (DOI) | Scholar Google |

[19] Pu Y, Li S, Wang L, Fang B, Bai X. Association Between High-Sensitivity C-Reactive Protein and Prognosis of Patients with Acute Cerebral Infarction. Neuropsychiatr Dis Treat. 2022; 18: 1771-1778.
| Digital Object Identifier (DOI) | PubMed (NCBI) | Scholar Google |

SEND

submitarticle

Send the manuscript online via the www.irdim.net platform
INFO

forauthors

We invite you to read the instructions for authors
READ

allissues

>>
We invite you to read the instructions for authors